Eszopiclone

BreastfeedingGeriatricPediatric
  • TRADE NAMES: Imovane (Sanofi-Aventis); Lunesta (Sunovion); Zimovane (Sanofi-Aventis)
  • INDICATIONS: Insomnia
  • CLASS: Hypnotic, non-benzodiazepine
  • HALF-LIFE: 6 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Alcohol, Antifungals, Cimetidine, CNS depressants, Conivaptan, CYP3A4 inhibitors and inducers, Dasatinib, Deferasirox, Droperidol, Erythromycin, Ethanol, Flumazenil, Ketoconazole, Levomepromazine, Lorazepam, Nefazodone, Nelfinavir, Olanzapine, Rifampin, Ritonavir, St John's Wort, Telithromycin, Tricyclic antidepressants, Valerian, Voriconazole

PREGNANCY CATEGORY: C

Our database has 99 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
HAIR.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
GENITOURINARY.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
OTIC.
RESPIRATORY.
OTHER.


Page last updated 04/09/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top